These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heparin therapy and monitoring: a role for the chromogenic antifactor Xa assay. Rosén S; Casoni MC Am Clin Lab; 2001 Aug; 20(7):35-8. PubMed ID: 11570272 [No Abstract] [Full Text] [Related]
12. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases. Melo FR; Mourão PA Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401 [TBL] [Abstract][Full Text] [Related]
13. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. Tran H; McRae S; Ginsberg J Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997 [TBL] [Abstract][Full Text] [Related]
15. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
17. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
18. Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface. Tapson VF Semin Respir Crit Care Med; 2008 Feb; 29(1):1-2. PubMed ID: 18302081 [No Abstract] [Full Text] [Related]
19. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195 [TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Vergouwen MD; Roos YB; Kamphuisen PW Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]